Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Holding the line on hepatic fat.

Alan R Saltiel

    Cell Metabolism
    |August 2, 2005
    PubMed
    Summary

    Insulin acutely lowers liver lipids by inhibiting fatty acid synthase, a key enzyme in fat production. This finding reveals a new mechanism for insulin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    One drug, five targets.

    Cell research·2026
    Same author

    Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover.

    Nature·2026
    Same author

    Time-Restricted Eating Promotes Weight Loss and Favorable Changes in Adipose in Obesity: The TREAD Randomized Control Trial.

    Obesity (Silver Spring, Md.)·2026
    Same author

    A nutrient-responsive AMPK/TBK1 circuit restricts adipocyte catabolism.

    JCI insight·2026
    Same author

    TANK-binding kinase 1 protects against MASH progression via mitochondrial quality control.

    Experimental & molecular medicine·2026
    Same author

    Multi-layered transcriptional control of glycogen metabolism coordinates thermogenic remodeling of white adipocytes in male mice.

    Nature communications·2025

    Area of Science:

    • Metabolic regulation
    • Hormonal signaling in liver
    • Lipid metabolism

    Background:

    • Chronic insulin elevation promotes hepatic lipogenesis and VLDL synthesis.
    • Acute insulin elevation paradoxically reduces liver lipids.
    • Fatty acid synthase is the rate-limiting enzyme in hepatic lipogenesis.

    Discussion:

    • The study by Najjar et al. (2005) proposes a novel mechanism for insulin's acute lipid-lowering effect in the liver.
    • This mechanism involves the inhibition of fatty acid synthase activity.
    • Understanding this pathway is crucial for metabolic disease research.

    Key Insights:

    • Acute insulin signaling directly inhibits the rate-limiting enzyme of hepatic lipogenesis, fatty acid synthase.
    • This provides a molecular explanation for the rapid reduction of liver lipids by insulin.
    • Identifies a new target for therapeutic intervention in metabolic disorders.

    Outlook:

    • Further research into the specific molecular players mediating fatty acid synthase inhibition by insulin.
    • Exploring the therapeutic potential of targeting this pathway for conditions like non-alcoholic fatty liver disease (NAFLD).
    • Investigating potential differences in this mechanism across various physiological and pathological states.

    Related Experiment Videos